## Membrane-Stabilizing Activity in Beta Blockers **Key Point:** Membrane-stabilizing activity (MSA), also called quinidine-like or local anesthetic activity, is a property of certain beta blockers that allows them to block sodium channels in cardiac and nerve membranes. This is independent of beta blockade. ### Classification by Selectivity and MSA | Beta Blocker | Selectivity | Membrane-Stabilizing Activity | |---|---|---| | **Propranolol** | **Non-selective** | **Yes** | | Nadolol | Non-selective | No | | Timolol | Non-selective | No | | Metoprolol | Beta-1 selective | No | | Atenolol | Beta-1 selective | No | | Bisoprolol | Beta-1 selective | No | | Nebivolol | Beta-1 selective | No | | Esmolol | Beta-1 selective | No | **High-Yield:** Propranolol is the **only commonly used beta blocker** with both non-selectivity AND membrane-stabilizing activity. This triple action (beta-1 blockade + beta-2 blockade + MSA) makes it uniquely effective in arrhythmias, especially those triggered by catecholamines or ischemia. **Clinical Pearl:** The membrane-stabilizing effect of propranolol contributes to its antiarrhythmic efficacy in conditions like atrial fibrillation, ventricular arrhythmias, and thyroid storm. This property is NOT present in modern selective beta-1 blockers. **Mnemonic:** **PINT** — Propranolol has **I**ntrinsic (membrane-stabilizing) activity (though this is a loose mnemonic; the key is to remember propranolol as the exception).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.